3.3. Lentiviral Expression of AR-V7 in a Novel C57BL/6 Syngeneic Prostate Tumor Cell Line Provides an Immunosuppressive Benefit Compared to an Empty Lentiviral Control Cell Line. Here, AR is linked to prostate neoplasm.